Status:
COMPLETED
Preoperative Inflammatory Biomarkers and Postoperative Day 1 Drain Amylase Value Predict Pancreatic Fistula After Pancreaticoduodenectomy
Lead Sponsor:
Campus Bio-Medico University
Conditions:
Pancreatic Fistula
Pancreas Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
Particularly, pancreatic fistula is the most common and serious complication after pancreaticoduodenectomy (PD) and is reported in up to 40% of cases. The aim of this retrospective single-center study...
Detailed Description
Data from a prospective collected database of 317 consecutive PDs performed at the University Campus Bio-Medico di Roma during the years 2005-2019, have been retrospectively analyzed. Local Ethical Co...
Eligibility Criteria
Inclusion
- Patients underwent pancreaticoduodenectomy (PD) for periampullary neoplasms
- Patients underwent PD with pancreaticojejunostomy reconstruction.
- Patient with data of blood count in first postoperative day
Exclusion
- None of the above criteria
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT04361682
Start Date
January 1 2005
End Date
April 1 2020
Last Update
April 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.